Cambridge Epigenetix, now biomodal, builds sequencing kits, software and analytics that let life scientists and clinical developers read genetic and epigenetic information from a single DNA sample using existing sequencing infrastructure.

Founders

• Prof. Sir Shankar Balasubramanian FRS · Founder
  He is the Herchel Smith Professor of Medicinal Chemistry at the University of Cambridge, a senior group leader at Cancer Research UK's Cambridge Institute, and a co-inventor of Solexa-Illumina sequencing.
• Bobby Yerramilli-Rao, PhD · Founder & Board Observer
  He is CSO & CVP, Corporate Strategy at Microsoft, previously spent nine years as co-founder and managing partner of Fusion Global Capital, and holds an M.A. from the University of Cambridge and a PhD from the University of Oxford.

Total raised

$146 million · as its sources put it, more than the rounds on record